Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer

Fig. 2

Correlation between clinicopathologic factors of lung cancer patients and the expression levels of Hsp90-beta in MPE and serum. a, b Poorly and undifferentiated patients revealed an up-regulated level of Hsp90-beta in MPE and serum than moderate and well differentiation (▲, P < 0.001); c, d The levels of Hsp90-beta in MPE and serum of lung cancer patients at T4 stage was significantly higher than that in patients at T3 stage and T2 (■, P = 0.009, =0.013). e, f Lymphatic invasion patients at N3 stage revealed an increased level of Hsp90-beta in MPE and serum than in those at N2 and N1 stage. MPE, malignant pleural effusion; T, the size of tumor; N, classification of lymph node metastases

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us